Class information for:
Level 1: VISFATIN//NAMPT//NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
11974 941 40.8 91%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
66 3       LEPTIN//ADIPONECTIN//ENDOCRINOLOGY & METABOLISM 84415
320 2             LEPTIN//ADIPONECTIN//RESISTIN 18237
11974 1                   VISFATIN//NAMPT//NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE 941

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 VISFATIN authKW 8207267 40% 68% 374
2 NAMPT authKW 1573415 8% 65% 75
3 NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE authKW 1199278 6% 70% 53
4 FK866 authKW 692227 3% 89% 24
5 PBEF authKW 685463 3% 81% 26
6 PRE B CELL COLONY ENHANCING FACTOR authKW 628196 2% 88% 22
7 CHS 828 authKW 500627 2% 86% 18
8 PRE B CELL COLONY ENHANCING FACTOR PBEF authKW 262830 1% 90% 9
9 APO866 authKW 227139 1% 100% 7
10 NAMPT PBEF VISFATIN authKW 129794 0% 100% 4

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Endocrinology & Metabolism 3340 24% 0% 222
2 Medicine, Research & Experimental 262 7% 0% 69
3 Cell Biology 247 10% 0% 96
4 Oncology 242 10% 0% 97
5 Obstetrics & Gynecology 202 5% 0% 49
6 Biochemistry & Molecular Biology 201 16% 0% 154
7 Nutrition & Dietetics 130 4% 0% 35
8 Pharmacology & Pharmacy 126 9% 0% 88
9 Chemistry, Medicinal 107 4% 0% 37
10 Physiology 77 4% 0% 39

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 INTRAMURAL DHHS 64897 0% 100% 2
2 PEDIAT EXPT TRANSLAT GENET 64897 0% 100% 2
3 GRP RECERCA MED LICADAIISPV 43263 0% 67% 2
4 ENDOCRINOL METAB GRP 35184 1% 14% 8
5 2ND OBSTET GYNECOL 32448 0% 100% 1
6 ARMY SHARE FUND HOSP 32448 0% 100% 1
7 ASSISTANT REPROD 32448 0% 100% 1
8 BASIC SCI BYTOM 32448 0% 100% 1
9 BEYIN DINAMIGI ARASTIRMA MERKEZI 32448 0% 100% 1
10 BEYIN DINAMIGI KOGNISYON KOMPLEKS SISTEMLER ARA 32448 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 OBESITY AND METABOLISM-MILAN 1348 0% 2% 2
2 CLINICAL ENDOCRINOLOGY 950 2% 0% 15
3 DIABETES RESEARCH AND CLINICAL PRACTICE 862 1% 0% 12
4 PEPTIDES 703 1% 0% 14
5 CNS NEUROSCIENCE & THERAPEUTICS 698 0% 1% 4
6 GYNECOLOGICAL ENDOCRINOLOGY 681 1% 0% 8
7 HORMONE AND METABOLIC RESEARCH 603 1% 0% 11
8 METABOLISM-CLINICAL AND EXPERIMENTAL 598 1% 0% 13
9 ARCHIVES ANIMAL BREEDING 530 0% 2% 1
10 ENDOKRYNOLOGIA POLSKA 504 0% 1% 3

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 VISFATIN 8207267 40% 68% 374 Search VISFATIN Search VISFATIN
2 NAMPT 1573415 8% 65% 75 Search NAMPT Search NAMPT
3 NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE 1199278 6% 70% 53 Search NICOTINAMIDE+PHOSPHORIBOSYLTRANSFERASE Search NICOTINAMIDE+PHOSPHORIBOSYLTRANSFERASE
4 FK866 692227 3% 89% 24 Search FK866 Search FK866
5 PBEF 685463 3% 81% 26 Search PBEF Search PBEF
6 PRE B CELL COLONY ENHANCING FACTOR 628196 2% 88% 22 Search PRE+B+CELL+COLONY+ENHANCING+FACTOR Search PRE+B+CELL+COLONY+ENHANCING+FACTOR
7 CHS 828 500627 2% 86% 18 Search CHS+828 Search CHS+828
8 PRE B CELL COLONY ENHANCING FACTOR PBEF 262830 1% 90% 9 Search PRE+B+CELL+COLONY+ENHANCING+FACTOR+PBEF Search PRE+B+CELL+COLONY+ENHANCING+FACTOR+PBEF
9 APO866 227139 1% 100% 7 Search APO866 Search APO866
10 NAMPT PBEF VISFATIN 129794 0% 100% 4 Search NAMPT+PBEF+VISFATIN Search NAMPT+PBEF+VISFATIN

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 GARTEN, A , SCHUSTER, S , PENKE, M , GORSKI, T , DE GIORGIS, T , KIESS, W , (2015) PHYSIOLOGICAL AND PATHOPHYSIOLOGICAL ROLES OF NAMPT AND NAD METABOLISM.NATURE REVIEWS ENDOCRINOLOGY. VOL. 11. ISSUE 9. P. 535 -546 123 70% 12
2 KENNEDY, BE , SHARIF, T , MARTELL, E , DAI, C , KIM, Y , LEE, PWK , GUJAR, SA , (2016) NAD(+) SALVAGE PATHWAY IN CANCER METABOLISM AND THERAPY.PHARMACOLOGICAL RESEARCH. VOL. 114. ISSUE . P. 274 -283 117 77% 0
3 GALLI, U , TRAVELLI, C , MASSAROTTI, A , FAKHFOURI, G , RAHIMIAN, R , TRON, GC , GENAZZANI, AA , (2013) MEDICINAL CHEMISTRY OF NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) INHIBITORS.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 56. ISSUE 16. P. 6279-6296 83 85% 39
4 SAMPATH, D , ZABKA, TS , MISNER, DL , O'BRIEN, T , DRAGOVICH, PS , (2015) INHIBITION OF NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) AS A THERAPEUTIC STRATEGY IN CANCER.PHARMACOLOGY & THERAPEUTICS. VOL. 151. ISSUE . P. 16 -31 66 80% 30
5 FILIPPATOS, TD , RANDEVA, HS , DERDEMEZIS, CS , ELISAF, MS , MIKHAILIDIS, DP , (2010) VISFATIN/PBEF AND ATHEROSCLEROSIS-RELATED DISEASES.CURRENT VASCULAR PHARMACOLOGY. VOL. 8. ISSUE 1. P. 12-28 102 78% 24
6 ROMACHO, T , SANCHEZ-FERRER, CF , PEIRO, C , (2013) VISFATIN/NAMPT: AN ADIPOKINE WITH CARDIOVASCULAR IMPACT.MEDIATORS OF INFLAMMATION. VOL. . ISSUE . P. - 86 77% 31
7 GROLLA, AA , TRAVELLI, C , GENAZZANI, AA , SETHI, JK , (2016) EXTRACELLULAR NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE, A NEW CANCER METABOKINE.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 173. ISSUE 14. P. 2182 -2194 77 78% 1
8 MONTECUCCO, F , CEA, M , BAUER, I , SONCINI, D , CAFFA, I , LASIGLIE, D , NAHIMANA, A , UCCELLI, A , BRUZZONE, S , NENCIONI, A , (2013) NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) INHIBITORS AS THERAPEUTICS: RATIONALES, CONTROVERSIES, CLINICAL EXPERIENCE.CURRENT DRUG TARGETS. VOL. 14. ISSUE 6. P. 637-643 72 82% 16
9 CHEN, H , WANG, SY , ZHANG, HY , NICE, EC , HUANG, CH , (2016) NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) IN CARCINOGENESIS: NEW CLINICAL OPPORTUNITIES.EXPERT REVIEW OF ANTICANCER THERAPY. VOL. 16. ISSUE 8. P. 827 -838 71 67% 0
10 CHANG, YH , CHANG, DM , LIN, KC , SHIN, SJ , LEE, YJ , (2011) VISFATIN IN OVERWEIGHT/OBESITY, TYPE 2 DIABETES MELLITUS, INSULIN RESISTANCE, METABOLIC SYNDROME AND CARDIOVASCULAR DISEASES: A META-ANALYSIS AND SYSTEMIC REVIEW.DIABETES-METABOLISM RESEARCH AND REVIEWS. VOL. 27. ISSUE 6. P. 515-527 49 82% 89

Classes with closest relation at Level 1


Rank Class id link
1 16106 CHEMERIN//VASPIN//OMENTIN
2 15453 WLDS//NAD BIOSYNTHESIS//WALLERIAN DEGENERATION
3 14574 LEPTIN//MATERNAL LEPTIN//ADIPONECTIN
4 12815 LEPTIN//MOL CELLULAR CARDIOL 7//NEIRID
5 11468 RESISTIN//RESISTIN LIKE MOLECULE BETA//RELM ALPHA
6 14760 APELIN//APJ//APELIN 13
7 913 SIRT1//SIRTUINS//SIRT3
8 10768 LEPTIN//ADIPONECTIN//LEPTIN RECEPTOR
9 437 ADIPONECTIN//ADIPONECTIN RECEPTOR//ADIPOQ
10 13143 RETINOL BINDING PROTEIN 4//RBP4//RETINOL BINDING PROTEIN

Go to start page